Target intelligence / Profile preview

Solute carrier family 18 member B1 (SLC18B1) (SLC18B1)

Target
SLC18B1
Molecular classification
Transporter, Major Facilitator Superfamily (MFS)
01

Overview

Solute carrier family 18 member B1 (SLC18B1), also known as the Vesicular Polyamine Transporter (VPAT), is a critical component of the human polyamine transport system (PTS) (Hiasa et al., 2014). It is the human ortholog of the yeast HOL1 protein and belongs to the Major Facilitator Superfamily (MFS) of transporters (UniProt Q6NT16). SLC18B1 functions by sequestering polyamines—essential organic cations like putrescine, spermidine, and spermine—into intracellular vesicles, thereby regulating their cytoplasmic availability and overall cellular homeostasis (Abdulrahman et al., 2021). Because polyamines are vital for cell growth and survival, cancer cells frequently upregulate SLC18B1 and the broader PTS to meet their increased metabolic demands (Casero et al., 2018). This makes SLC18B1 a significant therapeutic target; inhibitors such as AMXT-1501 are currently being evaluated in clinical trials, often in combination with polyamine synthesis inhibitors like eflornithine (DFMO), to starve tumors of these essential nutrients (ClinicalTrials.gov, NCT03538886). Additionally, the transporter's high activity in malignant cells allows it to be exploited for the targeted delivery of polyamine-drug conjugates, which use the PTS as a Trojan horse to internalize cytotoxic agents (Palmer & Wallace, 2010).

Other names
Vesicular polyamine transporterVPATHol1-associated transporterSLC18B1Solute carrier family 18 member B1
02

Mechanism of action

Competitive inhibition of polyamine uptake and vesicular sequestration; targeted delivery of polyamine-conjugated cytotoxic agents

03

Biological functions

Polyamine transportVesicular sequestration of polyaminesRegulation of intracellular polyamine homeostasis
04

Disease associations

CancerNeuroblastomaPancreatic cancerNeurodegenerative disease
05

Safety considerations

Systemic polyamine depletion toxicityGastrointestinal side effectsFunctional redundancy with other transporters like ATP13A3
06

Interacting drugs

AMXT-1501

2 more in the full profile.

07

Biomarkers

Intracellular polyamine levelsSLC18B1 expressionODC1 expression

Beyond the preview

Go deeper on Solute carrier family 18 member B1 (SLC18B1) (SLC18B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 18 member B1 (SLC18B1) (SLC18B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call